Gain Therapeutics, Inc. (GANX)

Gain Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.54	20.84	10.39	11.79	7.31	36.88
Short-Term Investments	-	-	-	5	12.83	-
Cash & Short-Term Investments	16.54	20.84	10.39	16.79	20.14	36.88
Cash Growth	82.35%	100.63%	-38.16%	-16.60%	-45.40%	392.21%
Other Current Assets	1.68	1.4	1.22	0.98	0.95	0.84
Total Current Assets	18.22	22.24	11.6	17.78	21.09	37.72
Net Property, Plant & Equipment	0.36	0.41	0.32	0.59	0.8	1.01
Other Intangible Assets	0.09	0.1	0.13	0.19	0.21	0.2
Long-Term Investments	-	-	-	-	1.94	-
Other Long-Term Assets	0.07	0.07	0.06	0.05	0.05	0.05
Total Assets	18.74	22.82	12.12	18.61	24.1	38.99
Accounts Payable	1.52	0.83	0.95	1.32	1.63	0.56
Current Portion of Long-Term Debt	0.1	0.1	0.11	0.12	0.11	0.1
Current Portion of Leases	0.12	0.12	0.16	0.23	0.23	0.22
Unearned Revenue	-	-	0.25	1.12	0.06	0.27
Other Current Liabilities	2.15	2.31	2.44	2.16	2.11	1.4
Total Current Liabilities	3.89	3.35	3.91	4.95	4.13	2.55
Long-Term Debt	0.27	0.3	0.33	0.45	0.5	0.59
Long-Term Leases	0.18	0.21	0.05	0.23	0.44	0.7
Other Long-Term Liabilities	0.39	0.39	0.49	0.4	0.16	0.33
Total Long-Term Liabilities	0.84	0.9	0.87	1.08	1.09	1.61
Total Liabilities	4.73	4.25	4.78	6.03	5.22	4.17
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	119.97	119.14	88.78	73.11	57.36	55.83
Accumulated Other Comprehensive Income	1	0.78	-0.25	0.25	0.04	-0.09
Retained Earnings	-101.36	-81.19	-60.78	-38.52	-20.93	-7.03
Shareholders' Equity	14.01	18.56	7.34	12.58	18.88	34.82
Total Liabilities & Equity	18.74	22.82	12.12	18.61	24.1	38.99
Total Debt	0.67	0.73	0.65	1.03	1.27	1.61
Net Cash (Debt)	15.87	20.11	9.73	15.77	18.86	35.27
Net Cash Growth	-21.08%	106.58%	-38.27%	-16.42%	-46.52%	466.03%
Net Cash Per Share	0.44	0.61	0.42	1.21	1.59	3.47
Book Value	14.01	18.56	7.34	12.58	18.88	34.82
Book Value Per Share	0.39	0.56	0.32	0.97	1.59	3.43
Tangible Book Value	13.92	18.46	7.21	12.38	18.67	34.61
Tangible Book Value Per Share	0.38	0.56	0.31	0.95	1.57	3.41

Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q